-
W648230-25mgWIC1 is a potent Wnt inhibitor. WIC1 can be used for the research of cancer.In VitroWICl (10 nM, 100 nM, 10μM, 100 μM) decrease TFC/LEF luciferase reporter activity in BEAS2B cell. WICl (10 nM, 100 nM, 10μM, 100 μM) shows minimal toxicity./nWICl
-
W648230-50mgWIC1 is a potent Wnt inhibitor. WIC1 can be used for the research of cancer.In VitroWICl (10 nM, 100 nM, 10μM, 100 μM) decrease TFC/LEF luciferase reporter activity in BEAS2B cell. WICl (10 nM, 100 nM, 10μM, 100 μM) shows minimal toxicity./nWICl
-
W648230-5mgWIC1 is a potent Wnt inhibitor. WIC1 can be used for the research of cancer.In VitroWICl (10 nM, 100 nM, 10μM, 100 μM) decrease TFC/LEF luciferase reporter activity in BEAS2B cell. WICl (10 nM, 100 nM, 10μM, 100 μM) shows minimal toxicity./nWICl
-
W651945-10mgWithanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and
-
W651945-1mgWithanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and
-
W651945-5mgWithanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and
-
W650417-100mgWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.Form:Solid
-
W650417-10mgWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.Form:Solid
-
W650417-25mgWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.Form:Solid
-
W650417-50mgWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.Form:Solid
-
W650417-5mgWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.Form:Solid
-
W656262-1mlWnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC 50 s of 13 nM.